Replies to post #209470 on Biotech Values

[DewDiligence]

CRBP -11% of whiffed phase-2 trial in CF (despite boast of positive outcome in PR header):

http://finance.yahoo.com/news/corbus-pharmaceuticals-reports-positive-topline-100000879.html